Research Progress on the Function of Chk2 Protein

Manda Sun, Jun PangJournal of Clinical Medicine Research 2022 · DOI

Abstract

Cell cycle checkpoint kinase 2 (Chk2) is a cell cycle monitoring kinase that exists widely in mammals. CHK2 is activated by phosphorylation and has a series of reactions with a variety of downstream proteins, which are active in various cellular reactions of organisms, such as DNA repair, cell cycle regulation and apoptosis. In this review, various biological functions of CHK2 are reviewed, with emphasis on cell cycle control, apoptosis, attenuated angiogenic mimicry formation and autophagy in tumor cells with p53 mutation. The summary of this review will help us to have a clearer and more comprehensive understanding of the biological functions of CHK2, and provide more effective treatment options for some diseases through the study of CHK2.

Introduction

In the high-stakes environment of cellular replication, DNA damage represents an existential threat. To prevent the propagation of mutations, cells rely on "checkpoint" proteins to halt the cell cycle and initiate either repair mechanisms or programmed cell death (apoptosis). While the protein p53 is famously known as the "guardian of the genome," it is mutated in over half of all human tumors, necessitating alternative pathways for genomic maintenance.

Cell cycle checkpoint kinase 2 (Chk2) is a central signal distributor that coordinates these critical responses. Far from being a simple "DNA damage sensor," Chk2 acts as an essential effector kinase that works both alongside and independently of p53. This review synthesizes recent research to clarify Chk2’s multi-faceted roles—from its structural mechanics to its influence on tumor metabolism—identifying new avenues for cancer therapy, particularly in p53-deficient environments.

Structural and Functional Architecture

Chk2 is a 543-residue protein characterized by three distinct domains: the SQ/TQ cluster (SCD), the Forkhead-associated (FHA) domain, and the Kinase domain (KD). These domains are structurally interdependent; the loss of function in any one domain effectively abrogates the kinase activity of the entire protein.

Once activated by the master regulator ATM (Ataxia-Telangiectasia Mutated) in response to double-strand breaks, Chk2 functions as a molecular router. It "splits" the signal to various downstream targets, including p53, BRCA1, E2F-1, and the Cdc25 phosphatase family, to determine the cell's fate based on the severity of the damage.

Mechanisms of Cell Cycle Control and Apoptosis

Chk2 maintains genomic stability primarily through the regulation of the cell cycle and the induction of apoptosis:

  • Cell Cycle Arrest: Chk2 targets the Cdc25 family of phosphatases. By inactivating Cdc25A and Cdc25C (specifically via S287 phosphorylation), it prevents the activation of Cyclin-Dependent Kinases (CDKs). This mechanism effectively "locks" the cell in the G1/S or G2/M phases, providing a window for DNA repair.
  • Apoptosis Induction: When DNA damage is too severe to repair, Chk2 promotes apoptosis. It regulates the stability of the transcription factor E2F-1 by phosphorylating it at Ser364, a critical pathway for inducing cell death.
  • Mitotic Quality Control: Beyond cycle arrest, Chk2 manages the machinery of division. It regulates centrosome assembly via MYPT1 and ensures correct mitotic spindle formation through BRCA1 phosphorylation.

Emerging Roles: Metabolism and Autophagy

Recent studies have expanded the known functional repertoire of Chk2 into tumor metabolism and cellular recycling:

  • The Chk2-PKM2 Axis: In p53-mutated cells, Chk2 plays a surprising role in suppressing tumor progression. It phosphorylates Pyruvate Kinase M2 (PKM2) at the S100 site, causing it to translocate from the nucleus to the cytoplasm. This prevents PKM2 from acting as a transcription factor for VEGF-A, thereby blocking vasculogenic mimicry (VM)—a process where tumor cells form their own fluid-conducting channels to bypass normal vasculature.
  • Autophagy Regulation: Chk2 promotes autophagy by phosphorylating Beclin 1 at Ser91 and Ser93. This phosphorylation disrupts the Beclin 1-Bcl-2 complex, allowing the cell to recycle components under metabolic stress or when reactive oxygen species (ROS) accumulate.

Conclusion and Future Directions

Chk2 is a versatile protein whose functions extend well beyond traditional DNA damage response. Its ability to regulate vasculogenic mimicry and autophagy, particularly in p53-mutant cancers, highlights its potential as a therapeutic target. However, Chk2 presents a "double-edged sword" in clinical practice: while inhibiting Chk2 might sensitize tumors to radiotherapy, activating its tumor-suppressive pathways could prevent progression. Future research focusing on the Chk2-PKM2 axis may provide more effective treatment options for aggressive malignancies, such as triple-negative breast cancer.

Summary updated

Abstract

Cell cycle checkpoint kinase 2 (Chk2) is a cell cycle monitoring kinase that exists widely in mammals. CHK2 is activated by phosphorylation and has a series of reactions with a variety of downstream proteins, which are active in various cellular reactions of organisms, such as DNA repair, cell cycle regulation and apoptosis. In this review, various biological functions of CHK2 are reviewed, with emphasis on cell cycle control, apoptosis, attenuated angiogenic mimicvm formation and autophagy in tumor cells with p53 mutation. The summary of this review will help us to have a clearer and more comprehensive understanding of the biological functions of CHK2, and provide more effective treatment options for some diseases through the study of CHK2.
BibTeX
@article{sun2022research,
  author = {Manda Sun and Jun Pang},
  title = {{Research Progress on the Function of Chk2 Protein}},
  journal = {Journal of Clinical Medicine Research},
  year = {2022},
  doi = {10.32629/jcmr.v3i1.718},
}
Figure